In colon cancer, a small number of CD133+ cells can maintain themselves as well as differentiate and re-establish tumour heterogeneity after serial transplantation (O'Brien et al, 2007; Ricci-Vitiani et al, 2007). Here, PROM1 is linked to malignant colon neoplasm.